Nanoviricides NNVC Balance Sheet (2010-2026)

NYSE NNVC
$1.01 -0.02 (-2.39%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

Nanoviricides Quarterly Balance Sheet

Periods 63 quarters
Latest Mar 2026

Nanoviricides reported total assets of $10.22M and total liabilities of $1.10M for the quarter ended Mar 2026, up 1.9% year over year. This balance sheet covers 63 quarters of results from Sep 2010 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
20.52M19.70M17.34M15.60M14.07M12.92M11.45M9.70M8.15M7.00M5.25M3.30M4.80M3.90M4.00M2.54M1.56M1.13M5.20M3.21M
Cash & Current Investments
20.52M19.70M17.34M15.60M14.07M12.92M11.45M9.70M8.15M7.00M5.25M3.30M4.80M3.90M4.00M2.54M1.56M1.13M5.20M3.21M
Receivables - OtherOther Receivables
Prepaid Assets
0.31M0.20M0.14M0.34M0.35M0.23M0.10M0.28M0.30M0.17M0.07M0.26M0.17M0.18M0.11M0.18M0.11M0.13M0.15M0.16M
Current Assets
20.82M19.89M17.52M15.95M14.42M13.15M11.55M9.93M8.45M7.14M5.32M3.52M4.97M4.04M4.07M2.73M1.67M1.25M5.30M3.38M
Non-Current Assets
Land & Improvements
0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M0.26M
Property, Plant & Equipment (Net)PP&E (Net)
9.08M8.93M8.94M8.80M8.69M8.56M8.42M8.29M8.11M7.93M7.75M7.60M7.51M7.37M7.17M6.98M6.83M6.79M6.66M6.53M
Long-Term Investments
Intangibles
0.46M0.46M0.46M0.46M0.34M0.46M0.34M0.46M0.33M0.33M0.33M0.33M0.46M0.32M0.32M0.32M0.46M0.46M0.46M0.46M
Goodwill & Intangibles
0.46M0.46M0.46M0.46M0.34M0.46M0.34M0.46M0.33M0.33M0.33M0.33M0.46M0.32M0.32M0.32M0.46M0.46M0.46M0.46M
Other Non-Current Assets
0.00M0.00M0.00M0.05M0.04M0.04M0.03M0.02M0.01M
Non-Current Assets
9.44M9.29M9.29M9.20M9.08M8.93M8.78M8.65M8.45M8.27M8.08M7.95M7.85M7.70M7.50M7.30M7.15M7.10M6.97M6.84M
Assets
30.26M29.18M26.81M25.14M23.49M22.08M20.33M18.58M16.90M15.42M13.40M11.46M12.82M11.74M11.57M10.03M8.82M8.36M12.27M10.22M
Liabilities
Current Liabilities
Accounts Payables
0.20M0.12M0.15M0.12M0.06M0.04M0.04M0.06M0.73M0.88M0.83M0.34M0.72M0.71M0.87M0.81M0.82M0.90M0.93M0.91M
Notes Payables
1.10M
Payables
1.30M0.12M0.15M0.12M0.06M0.04M0.04M0.06M0.73M0.88M0.83M0.34M0.72M0.71M0.87M0.81M0.82M0.90M0.93M0.91M
Accumulated Expenses
0.02M0.02M0.02M0.03M0.05M0.02M0.05M0.04M0.14M0.34M0.18M0.26M0.26M0.28M0.07M0.03M0.03M0.03M0.05M0.03M
Short term Debt
0.03M0.71M0.17M0.07M0.21M0.43M0.37M0.24M
Current Taxes
Total Current Liabilities
0.35M0.87M0.34M0.39M0.41M0.52M0.46M0.35M0.53M0.95M0.95M0.81M1.36M1.63M1.18M1.20M1.31M1.18M1.20M1.07M
Non-Current Liabilities
Non-Current Debt
0.10M0.02M0.16M0.09M0.02M1.50M1.50M
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities
0.35M0.87M0.34M0.39M0.41M0.52M0.46M0.35M2.03M2.45M0.95M0.81M1.36M1.63M1.20M1.20M1.30M1.20M1.20M1.10M
Shareholder's Equity
Total Debt
1.23M0.73M0.17M0.24M0.31M0.46M0.37M0.24M1.50M1.50M
Common Equity
29.91M28.31M26.47M24.76M23.08M21.56M19.87M18.23M14.87M12.97M12.45M10.65M11.46M10.11M10.39M8.83M7.52M7.17M11.07M9.15M
Liabilities and Shareholders Equity
30.26M29.18M26.81M25.14M23.49M22.08M20.33M18.58M16.90M15.42M13.40M11.46M12.82M11.74M11.57M10.03M8.82M8.36M12.27M10.22M
Retained Earnings
144.28M145.30M145.37M145.46M145.57M145.61M145.67M145.73M145.95M146.02M147.62M147.67M150.84M152.61M154.92M155.58M156.36M157.80M163.92M163.99M
Preferred Shares
372.00482.00482.00484.00485.00495.00495.00497.005.005.009.009.009.009.009.009.009.009.009.009.00